
    
      PRIMARY OBJECTIVE:

      I. To determine if regional nodal radiation therapy prolongs the time to regional recurrence.

      OUTLINE: Patients are randomized to 1 of 2 groups.

      GROUP I: Patients receive adjuvant immunotherapy and nodal radiation therapy (30 Gy in 5
      treatments over 2-2.5 weeks).

      GROUP II: Patients receive adjuvant immunotherapy alone.

      After completion of study treatment, patients are followed up every 3 months for 2 years and
      then every 6 months for 3 years.
    
  